Neuronetics Statistics
Total Valuation
Neuronetics has a market cap or net worth of $156.15 million. The enterprise value is $218.93 million.
Important Dates
The last earnings date was Tuesday, November 4, 2025, before market open.
| Earnings Date | Nov 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Neuronetics has 68.49 million shares outstanding. The number of shares has increased by 95.24% in one year.
| Current Share Class | 68.49M |
| Shares Outstanding | 68.49M |
| Shares Change (YoY) | +95.24% |
| Shares Change (QoQ) | +1.71% |
| Owned by Insiders (%) | 5.87% |
| Owned by Institutions (%) | 27.21% |
| Float | 43.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.02 |
| Forward PS | 0.95 |
| PB Ratio | 5.70 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.24, with a Debt / Equity ratio of 2.89.
| Current Ratio | 2.24 |
| Quick Ratio | 1.62 |
| Debt / Equity | 2.89 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.24 |
Financial Efficiency
Return on equity (ROE) is -218.99% and return on invested capital (ROIC) is -25.85%.
| Return on Equity (ROE) | -218.99% |
| Return on Assets (ROA) | -21.21% |
| Return on Invested Capital (ROIC) | -25.85% |
| Return on Capital Employed (ROCE) | -31.98% |
| Revenue Per Employee | $181,387 |
| Profits Per Employee | -$62,154 |
| Employee Count | 716 |
| Asset Turnover | 1.18 |
| Inventory Turnover | 13.74 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +91.60% in the last 52 weeks. The beta is 0.67, so Neuronetics's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | +91.60% |
| 50-Day Moving Average | 2.92 |
| 200-Day Moving Average | 3.71 |
| Relative Strength Index (RSI) | 32.90 |
| Average Volume (20 Days) | 1,623,166 |
Short Selling Information
The latest short interest is 5.81 million, so 8.48% of the outstanding shares have been sold short.
| Short Interest | 5.81M |
| Short Previous Month | 5.81M |
| Short % of Shares Out | 8.48% |
| Short % of Float | 13.44% |
| Short Ratio (days to cover) | 4.69 |
Income Statement
In the last 12 months, Neuronetics had revenue of $129.87 million and -$44.50 million in losses. Loss per share was -$0.77.
| Revenue | 129.87M |
| Gross Profit | 66.10M |
| Operating Income | -37.27M |
| Pretax Income | -44.61M |
| Net Income | -44.50M |
| EBITDA | -34.21M |
| EBIT | -37.27M |
| Loss Per Share | -$0.77 |
Full Income StatementBalance Sheet
The company has $27.97 million in cash and $90.75 million in debt, giving a net cash position of -$62.78 million or -$0.92 per share.
| Cash & Cash Equivalents | 27.97M |
| Total Debt | 90.75M |
| Net Cash | -62.78M |
| Net Cash Per Share | -$0.92 |
| Equity (Book Value) | 31.36M |
| Book Value Per Share | 0.40 |
| Working Capital | 35.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$29.88 million and capital expenditures -$674,000, giving a free cash flow of -$30.55 million.
| Operating Cash Flow | -29.88M |
| Capital Expenditures | -674,000 |
| Free Cash Flow | -30.55M |
| FCF Per Share | -$0.45 |
Full Cash Flow StatementMargins
Gross margin is 50.89%, with operating and profit margins of -28.69% and -34.27%.
| Gross Margin | 50.89% |
| Operating Margin | -28.69% |
| Pretax Margin | -34.35% |
| Profit Margin | -34.27% |
| EBITDA Margin | -26.34% |
| EBIT Margin | -28.69% |
| FCF Margin | n/a |
Dividends & Yields
Neuronetics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -95.24% |
| Shareholder Yield | -95.24% |
| Earnings Yield | -28.50% |
| FCF Yield | -19.57% |
Analyst Forecast
The average price target for Neuronetics is $7.00, which is 207.02% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 207.02% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 25.37% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Neuronetics has an Altman Z-Score of -3.01 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.01 |
| Piotroski F-Score | 2 |
